Yesterday I briefly wondered about the sharp rise in $CPRX (-0,28%) yesterday. According to company data, the company is delivering really strong sales figures and solid cash flow. I am currently still slightly in the red, but in my opinion the recovery is only a matter of time. Thanks to @Aktienhauptmeister for the presentation back then.
CORAL GABLES, Fla.., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing and commercializing novel medicines for people living with rare and difficult-to-treat diseases, today announced that its Board of Directors has authorized a new share repurchase program to repurchase up to $200 million of shares of Catalyst's outstanding common stock between October 1, 2025, and December 31, 2026